Rho kinase inhibitors
The present invention relates to compounds of formula (I):and pharmaceutically acceptable salts thereof, wherein R1 and R2 are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.
Boehringer Ingelheim International GmbH
C A A C C C A A A A C A A C C C C C A A C C C A A A A A A
C07D A61P A61P C07D C07D C07D A61P A61P A61P A61P C07D A61P A61P C07D C07D C07D C07D C07D A61P A61P C07D C07D C07D A61P A61P A61P A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Robert Brian Nicholas Jennifer A. Daniel Richard Ronald John Yunlong Fariba Erick Richard Roush Xiang Sabine Lana Louise
Sibley Cook Kowalski Marshall Sorcek Zhang Soleymanzadeh Young Li Schlyer Smith-Keenan